Fluorogenic Pyrosequencing in Microreactors  by Greenleaf, William J. et al.
368a Tuesday, March 8, 2011helices are only straight because the voltage sensor, via the S4-S5 linker, is
held in the down position by the transmembrane voltage. This has impor-
tant consequences for efforts to try and crystallize a voltage-gated potas-
sium channel in the closed state.
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Living organisms use voltage to transmit information over distances ranging
from nanometers to meters. Traditional probes of voltage rely on physical
electrodes which are invasive and can be used only in limited numbers.
Here we present a voltage-sensitive fluorescent protein based on green-
absorbing proteorhodopsin. The Proteorhodopsin Optical Proton Sensor
(PROPS) has a far red excitation, a near infrared emission, is highly photo-
stable, and is exquisitely sensitive to membrane potential. This protein has
no homology to GFP or to any existing indicator of membrane potential. Us-
ing PROPS we have recorded for the first time electrical activity in live bac-
teria and saw 5-fold changes in fluorescence. We have also put it into
eukaryotic cells in order to record electrical activity from neurons. PROPS
represents a new optogenetic tool in the quest for an all optical neural
interface.
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Typical dimensions of cellular components are on the order of a few nanome-
ters and their diverse cellular functions often involve conformational changes
that require movements ranging from fractions of a nanometer up to tens of
nanometers. The current state of the art tool for studying conformational dy-
namics is single molecule Fluorescence Resonance Energy Transfer (FRET),
whereby energy transfer between two fluorescent dyes is correlated to their spa-
tial separation; however, distance predictions made by FRET theory are only
accurate in the range of ~ 3-7 nm, and the working range is limited to below
10 nm. Furthermore, quantitative distance predictions require case-specific
calibrations.
Here we present a nanoscale device constructed by DNA origami that improves
the quantitative accuracy of FRET distance predictions and expands its poten-
tial working range. The device integrates 3d structures built from self-
assembled DNA, attachment sites for molecules of interest, sites for surface
immobilization, and fluorescent markers for the direct visualization of biomo-
lecular dimensions and dynamics by FRET. The device takes advantage of
a distance calibration that can be generally applied to any molecule of interest.
We have demonstrated that the device can easily achieve 1 nm distance reso-
lution. For the purpose of proof-of-concept studies we specifically integrated
a piece of double stranded DNA (dsDNA) containing a recognition sequence
for Catabolite Activator Protein (CAP), which is know to bend dsDNA upon
binding, between the arms of this device. The bending angle will be evaluated
with single particle electron microscopy (EM), and FRET microscopy will be
employed in solution to resolve real-time kinetics and deformations of CAP-
DNA binding.
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Purpose: Despite the use of a variety of differentiation protocols, no method
exists to prospectively generate specific phenotypes of human embryonic
stem cell (hESC)-derived cardiomyocytes (CM) such as pacemaker cells. We
introduced light-activated channelrhodopsin-2 (ChR2) into hESC, and by using
in vitro and in silico approaches, we were able to optogenetically synchronize
hESC-CM, both experimentally and computationally.
Methods: We experimentally introduced ChR2 coupled to yellow fluores-
cent protein (YFP) into undifferentiatedhESC via a lentiviral vector and
tested for expression via PCR, flow cytometry (FC), and immunocytochem-
istry (ICC). hESCChR2þ were sorted, expanded, and tested for pluripotency.Via directed differentiation, wildtype hESC-CM and ChR2-CM were pro-
duced and subjected to both electrical and optical stimulation. Electrical,
biochemical, and mechanical signals were then assessed by patch clamping,
multielectrode arrays (MEAs), and video microscopy. To complement our
in vitro approach with in silico analyses, we introduced ChR2 into an ionic
cardiac cell model.
Results: ChR2 was stably transduced into undifferentiated hESC and the result-
ing hESCChR2þ pluripotent line could be differentiated into CM, all confirmed
by PCR, FC, ICC, and electrophysiological methods. Both WT-CM and ChR2-
CM responded to traditional electrical stimulation and produced similar cal-
cium and contractility features but only ChR2-CM could be synchronized by
optical stimulation. In addition, by calibrating our ionic cell model with single
cell action potential (AP) readings, we were able to virtually probe the impact
of photostimulation stimulus amplitude, pulse width, and frequency on overall
AP characteristics.
Conclusions: Here we show for the first time that ChR2 can enable in vitro and
in silico optical control of hESC-CM. The long-term application of optical
stimulation could potentially lead to specific synchronous phenotypes of
hESC-CM. This, in turn, would contribute significantly towards creating effec-
tive therapies for cardiovascular disease.
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High-throughput sequencing techniques are revolutionizing biology and
promise to have a significant impact on the future of medicine. We have
developed a scalable, parallel, low-cost method for nucleic acid sequencing
that combines resealable microreactors and terminal-phosphate labeled fluo-
rogenic nucleotides. To accomplish this, we have fabricated arrays of mi-
croreactors in polydimethylsiloxane (PDMS) that can be reversibly sealed,
and have developed techniques for immobilizing different populations of
identical DNA fragments specifically and efficiently within these microreac-
tors. We have synthesized a series of terminal-phosphate labeled fluoro-
genic substrates for DNA polymerase which, upon their incorporation
into a primer strand of DNA and subsequent digestion by a phosphatase,
generate fluorescent dye molecules that are effectively trapped in the micro-
reactors. By sequentially interrogating the microreactor array with solutions
containing different fluorogenic nucleotide substrates, and recording which
microreactors generate fluorescence, we can sequence the immobilized
DNA. This "fluorogenic pyrosequencing" method promises significant ad-
vantages over existing sequencing technologies, and has the potential to
be elegantly interfaced with the wide variety of PDMS-based microfluidic
devices suitable for the preparation and amplification of DNA or RNA
for sequencing, opening the possibility of one-chip, sample-to-sequence
capabilities.
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During their life cycle viruses hijack host networks for their own needs. Dis-
covering the basic biochemical interactions between viral proteins and host
proteins is a crucial step towards understanding the viral life cycle. Due to
the size of the host proteome high-throughput methods are needed to screen
for such viral-host interactions. Despite significant efforts, conventional tools
such as Yeast Two Hybrid largely failed. The failure is more pronounced
when it comes to membrane associated proteins. We have designed PING,
a sensitive high-throughput microfluidic assay that allows the screen of
viral-host protein interactions as well as screen for inhibitors of such interac-
tions. In a proof of principle experiment we screened the two HDV proteins
and HCV NS5A against a hundred human proteins. We identified 7, 4 and
6 novel partners for sHDAg, LHDAg and NS5A, respectively. The average
sensitivity of a single experiment (known partners identified out of all known
partners included) was 62%, similar to bacterial interaction data previously
measured with PING. The cumulative sensitivity in 4 experiments was
100%. These results pave the way for a whole proteome screen, which will
allow us the horizontal overview we need into the biochemical network of vi-
ruses inside their host.
